Article
Attitudes toward information about genetic risk for cognitive impairment after cancer chemotherapy: breast cancer survivors compared with healthy controls.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Jul 2010
Andrykowski Michael A, Burris Jessica L, Walsh Erin, Small Brent J, Jacobsen Paul B
Abstract excerpt
PURPOSE: The trend toward personalized medicine will involve cancer treatment increasingly being tailored to the genetic characteristics of individuals. However, the availability of genetic information does not imply this information is desired or would impact treatment decision making. METHODS: One hundred sixty breast cancer survivors (BC group) and 205 healthy controls (HC group) were randomly assigned to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
